HonorHealth Research Institute
27
1
3
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
29.6%
8 terminated/withdrawn out of 27 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
44%
7 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients
Role: lead
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
Role: lead
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
Role: lead
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
Role: lead
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
Role: lead
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Role: lead
The Seven Trial: Exploiting the Unfolded Protein Response
Role: lead
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Role: lead
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer
Role: lead
Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
Role: lead
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
Role: lead
Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Role: collaborator
SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy
Role: lead
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
Role: lead
Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine
Role: lead
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Role: lead
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Role: lead
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
Role: collaborator
Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy
Role: lead
Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
Role: lead